LRP16 integrates into NF-κB transcriptional complex and is required for its functional activation

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Wu, Zhiqiang ^a   Li, Yazhuo ^a   Li, Xiaolei ^a   Ti, Dongdong ^a   Zhao, Yali ^a   Si, Yiling ^a   Mei, Qian ^a   Zhao, Po ^a   Fu, Xiaobing ^a   Han, Weidong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN LRP16; PROTEIN P300; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; LRP16 PROTEIN, HUMAN; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TRANSPORT; REGULATORY MECHANISM; RNA INTERFERENCE; STOMACH CARCINOMA; TRANSCRIPTION INITIATION; TUMOR CELL; UPREGULATION; ACTIVE TRANSPORT; CELL LINE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GEL MOBILITY SHIFT ASSAY; GENETICS; HELA CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTIVE TRANSPORT, CELL NUCLEUS; APOPTOSIS; CELL LINE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NEOPLASM PROTEINS; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79953319238     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018157     Document Type: Article

References (53)

1. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S, (1995) Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 9: 2723-2735.
2. Chen LF, Greene WC, (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5: 392-401.
3. Hayden MS, Ghosh S, (2008) Shared principles in NF-kappaB signaling. Cell 132: 344-362.
4. Ghosh S, May MJ, Kopp EB, (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260.
5. Li Q, Verma IM, (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734.
6. Baldwin AS Jr, (2001) Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 107: 3-6.
7. Karin M, (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436.
8. Darnell JE Jr, (2002) Transcription factors as targets for cancer therapy. Nat Rev Cancer 2: 740-749.
9. Karin M, Yamamoto Y, Wang QM, (2004) The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 3: 17-26.
10. Lee DF, Hung MC, (2008) Advances in targeting IKK and IKK-related kinases for cancer therapy. Clin Cancer Res 14: 5656-5662.
11. Chan HM, La Thangue NB, (2001) p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 114: 2363-2373.
12. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, et al. (1997) CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A 94: 2927-2932.
13. Covic M, Hassa PO, Saccani S, Buerki C, Meier NI, et al. (2005) Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression. EMBO J 24: 85-96.
14. Hassa PO, Haenni SS, Buerki C, Meier NI, Lane WS, et al. (2005) Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. J Biol Chem 280: 40450-40464.
15. Karras GI, Kustatscher G, Buhecha HR, Allen MD, Pugieux C, et al. (2005) The macro domain is an ADP-ribose binding module. EMBO J 24: 1911-1920.
16. Pehrson JR, Fried VA, (1992) MacroH2A, a core histone containing a large nonhistone region. Science 257: 1398-1400.
17. Aguiar RC, Takeyama K, He C, Kreinbrink K, Shipp MA, (2005) B-aggressive lymphoma family proteins have unique domains that modulate transcription and exhibit poly(ADP-ribose) polymerase activity. J Biol Chem 280: 33756-33765.
18. Allen MD, Buckle AM, Cordell SC, Lowe J, Bycroft M, (2003) The crystal structure of AF1521 a protein from Archaeoglobus fulgidus with homology to the non-histone domain of macroH2A. J Mol Biol 330: 503-511.
19. Ahel D, Horejsi Z, Wiechens N, Polo SE, Garcia-Wilson E, et al. (2009) Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science 325: 1240-1243.
20. Timinszky G, Till S, Hassa PO, Hothorn M, Kustatscher G, et al. (2009) A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation. Nat Struct Mol Biol 16: 923-929.
21. Goenka S, Boothby M, (2006) Selective potentiation of Stat-dependent gene expression by collaborator of Stat6 (CoaSt6), a transcriptional cofactor. Proc Natl Acad Sci U S A 103: 4210-4215.
22. Han WD, Zhao YL, Meng YG, Zang L, Wu ZQ, et al. (2007) Estrogenically regulated LRP16 interacts with estrogen receptor alpha and enhances the receptor's transcriptional activity. Endocr Relat Cancer 14: 741-753.
23. Yang J, Zhao YL, Wu ZQ, Si YL, Meng YG, et al. (2009) The single-macro domain protein LRP16 is an essential cofactor of androgen receptor. Endocr Relat Cancer 16: 139-153.
24. Neuvonen M, Ahola T, (2009) Differential activities of cellular and viral macro domain proteins in binding of ADP-ribose metabolites. J Mol Biol 385: 212-225.
25. Han WD, Mu YM, Lu XC, Xu ZM, Li XJ, et al. (2003) Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report. Endocr Relat Cancer 10: 217-224.
26. Sun S, Tang Y, Lou X, Zhu L, Yang K, et al. (2007) UXT is a novel and essential cofactor in the NF-kappaB transcriptional enhanceosome. J Cell Biol 178: 231-244.
27. Krikos A, Laherty CD, Dixit VM, (1992) Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J Biol Chem 267: 17971-17976.
28. Sun SC, Ganchi PA, Ballard DW, Greene WC, (1993) NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 259: 1912-1915.
29. Deng L, Wang C, Spencer E, Yang L, Braun A, et al. (2000) Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103: 351-361.
30. Muzio M, Ni J, Feng P, Dixit VM, (1997) IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278: 1612-1615.
31. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, et al. (1998) The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8: 297-303.
32. Li YZ, Zhao P, Han WD, (2009) Clinicopathological significance of LRP16 protein in 336 gastric carcinoma patients. World J Gastroenterol 15: 4833-4837.
33. O'Malley BW, Qin J, Lanz RB, (2008) Cracking the coregulator codes. Curr Opin Cell Biol 20: 310-315.
34. Wolf IM, Heitzer MD, Grubisha M, DeFranco DB, (2008) Coactivators and nuclear receptor transactivation. J Cell Biochem 104: 1580-1586.
35. Aggarwal BB, (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208.
36. Rayet B, Gelinas C, (1999) Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18: 6938-6947.
37. Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, et al. (2001) Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 7: 4136-4142.
38. Yamanaka N, Sasaki N, Tasaki A, Nakashima H, Kubo M, et al. (2004) Nuclear factor-kappaB p65 is a prognostic indicator in gastric carcinoma. Anticancer Res 24: 1071-1075.
39. Xi HQ, Zhao P, Han WD, (2010) Clinicopathological significance and prognostic value of LRP16 expression in colorectal carcinoma. World J Gastroenterol 16: 1644-1648.
40. Zhao P, Lu Y, Han W, (2010) Clinicopathological significance and prognostic value of leukemia-related protein 16 expression in invasive ductal breast carcinoma. Cancer Sci 101: 2262-2268.
41. Baselga J, Norton L, (2002) Focus on breast cancer. Cancer Cell 1: 319-322.
42. Isaacs W, De Marzo A, Nelson WG, (2002) Focus on prostate cancer. Cancer Cell 2: 113-116.
43. De Bosscher K, Vanden Berghe W, Haegeman G, (2006) Cross-talk between nuclear receptors and nuclear factor kappaB. Oncogene 25: 6868-6886.
44. Frasor J, Weaver A, Pradhan M, Dai Y, Miller LD, et al. (2009) Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer. Cancer Res 69: 8918-8925.
45. Ko S, Shi L, Kim S, Song CS, Chatterjee B, (2008) Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alpha. Mol Endocrinol 22: 273-286.
46. Jin RJ, Lho Y, Connelly L, Wang Y, Yu X, et al. (2008) The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth. Cancer Res 68: 6762-6769.
47. Zhou Y, Eppenberger-Castori S, Eppenberger U, Benz CC, (2005) The NFkappaB pathway and endocrine-resistant breast cancer. Endocr Relat Cancer 12 (Suppl 1): S37-46.
48. Zhou Y, Eppenberger-Castori S, Marx C, Yau C, Scott GK, et al. (2005) Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers. Int J Biochem Cell Biol 37: 1130-1144.
49. Han WD, Si YL, Zhao YL, Li Q, Wu ZQ, et al. (2008) GC-rich promoter elements maximally confers estrogen-induced transactivation of LRP16 gene through ERalpha/Sp1 interaction in MCF-7 cells. J Steroid Biochem Mol Biol 109: 47-56.
50. Zhao YL, Han WD, Li Q, Mu YM, Lu XC, et al. (2005) Mechanism of transcriptional regulation of LRP16 gene expression by 17-beta estradiol in MCF-7 human breast cancer cells. J Mol Endocrinol 34: 77-89.
51. Meng YG, Han WD, Zhao YL, Huang K, Si YL, et al. (2007) Induction of the LRP16 gene by estrogen promotes the invasive growth of Ishikawa human endometrial cancer cells through the downregulation of E-cadherin. Cell Res 17: 869-880.
52. Tian L, Wu Z, Zhao Y, Meng Y, Si Y, et al. (2009) Differential induction of LRP16 by liganded and unliganded estrogen receptor alpha in SKOV3 ovarian carcinoma cells. J Endocrinol 202: 167-177.
53. Han W, Wu Z, Zhao Y, Meng Y, Si Y, et al. (2009) FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells. Nucleic Acids Res 37: 3996-4009.